Evidence map›Paper›PMID 41041542›Full record

ArticleResearch square2025

CD1d+ Goblet Cells Expand Colon-Resident Immature, Intermediate and Differentiated iNKT Cells to Limit Colitis.

Vini John, Bibiana Barrios, Jacqueline D Wang, Sreeram Udayan, Kathryn A Knoop, Alexandria N Floyd, Elisabeth L Joyce, Ellen M Schill, Sushma Sundas, Keely G McDonald and 6 more

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Vini JohnThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Bibiana BarriosDivision of Gastroenterology, Department of Internal Medicine, Washington University in Saint Louis School of Medicine, St. Louis, MO, USA 63110.
Jacqueline D WangThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.ORCID 0009-0004-1695-2636
Sreeram UdayanThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.ORCID 0000-0003-3778-9968
Kathryn A KnoopDepartment of Immunology, Mayo Clinic, Rochester, MN 55901.
Alexandria N FloydDivision of Gastroenterology, Department of Internal Medicine, Washington University in Saint Louis School of Medicine, St. Louis, MO, USA 63110.
Elisabeth L JoyceDivision of Gastroenterology, Department of Internal Medicine, Washington University in Saint Louis School of Medicine, St. Louis, MO, USA 63110.
Ellen M SchillDivsion of Newborn Medicine, Department of Pediatrics, Washington University in Saint Louis School of Medicine, St. Louis, MO, USA 63110.
Sushma SundasDivision of Gastroenterology, Department of Internal Medicine, Washington University in Saint Louis School of Medicine, St. Louis, MO, USA 63110.
Keely G McDonaldDivision of Gastroenterology, Department of Internal Medicine, Washington University in Saint Louis School of Medicine, St. Louis, MO, USA 63110.
Reyka G JayasingheDivision of Oncology, Department of Medicine, Washington University in Saint Louis School of Medicine, St. Louis, MO, USA 63110.
Melissa MaversDivision of Hematology and Oncology, Department of Pediatrics, Washington University in Saint Louis School of Medicine, St. Louis, MO, USA 63110.ORCID 0000-0001-5452-9530
Richard S BlumbergDivision of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.ORCID 0000-0002-9704-248X
Chyi Song HsiehDivision of Rheumatology, Department of Internal Medicine, Washington University in Saint Louis School of Medicine, St. Louis, MO, USA 63110.
Brigida RusconiThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.ORCID 0000-0001-8422-122X
Rodney D NewberryDivision of Gastroenterology, Department of Internal Medicine, Washington University in Saint Louis School of Medicine, St. Louis, MO, USA 63110.ORCID 0000-0002-4152-5191

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
MOLECULAR CHARACTERIZATION OF MUCOSAL LYMPHOCYTESR01DK044319 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI Richard S Blumberg · 1992 to 2026
$10.4M
cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine75N93022D00005 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI HASSELL, THOMAS · 2022 to 2025
$8.0M
GOBLET CELLS IN INTESTINAL IMMUNE HOMEOSTATSISR01DK097317 · NIDDK · WASHINGTON UNIVERSITY · PI NEWBERRY, RODNEY D · 2012 to 2025
$5.6M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
Immune interactions with commensal microbes in early lifeR01AI173220 · NIAID · WASHINGTON UNIVERSITY · PI CHYI S HSIEH, Rodney D Newberry · 2023 to 2026
$2.8M
Gut Intrinsic Inflammatory ResponsesU01AI163073 · NIAID · WASHINGTON UNIVERSITY · PI HSIEH, CHYI S, NEWBERRY, RODNEY D · 2021 to 2025
$2.6M
Pro-Type 2 Goblet Cell Antigen Passages in Food Sensitization and ReactivityR37AI112626 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SIMON Patrick HOGAN, Rodney D Newberry · 2023 to 2026
$2.2M
Immunosuppressive human invariant natural killer T cells for prevention of graft-versus-host diseaseK08HL151809 · NHLBI · WASHINGTON UNIVERSITY · PI MAVERS, MELISSA · 2020 to 2024
$833k
S1P as regulator of neonatal mucosal immune development and injuryK01DK125606 · NIDDK · WASHINGTON UNIVERSITY · PI RUSCONI, BRIGIDA AGNESE · 2020 to 2024
$679k
NHLBI NIH HHS 75N92020D00005NHLBI NIH HHS K08 HL151809NIAID NIH HHS 75N93022D00005NIAID NIH HHS 75N93023D00005NIAID NIH HHS R01 AI173220NIAID NIH HHS R37 AI112626NIAID NIH HHS U01 AI163073NIDA NIH HHS 75N95020D00005NIDDK NIH HHS K01 DK125606NIDDK NIH HHS P30 DK052574NIDDK NIH HHS R01 DK044319NIDDK NIH HHS R01 DK097317ORFDO NIH HHS 75N99020D00005
6 · The paper itself

Abstract

Invariant Natural Killer T (iNKT) cells recognize glycolipid antigens presented on CD1d and rapidily respond to direct immune responses. iNKT cells develop in the thymus and migrate to peripheral tissues in what has been presumed to be differentiated/committed states. Accordingly, colonic iNKT cells are established in early life, considered to remain 'fixed' post-weaning, and determine life-long colitis susceptibility. Using single cell RNA sequencing (scRNA-seq), we demonstrate that humans and mice contain colonic iNKT populations transcriptionally resembling immature and intermediate thymic iNKT precursors. Contrary to prevailing paradigms, we demonstrate colonic iNKT cell populations expand in adult mice when CD1d expressing colonic goblet cells form goblet cell-associated antigen passages. Expansion preferentially affected intermediate iNKT cells, was durable, and protective in a colitis model. These studies reveal that the adult colon harbors iNKT cells with retained plasticity and uncover a novel role for goblet cells as unconventional antigen presenting cells regulating this axis.

Identifiers

PMID41041542
PMCPMC12486123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.